Terran Biosciences announces licensing deal with Columbia University for exclusive worldwide rights to proprietary CNS biomarker software platform
NEW YORK, March 16, 2022 /PRNewswire/ — Terran Biosciences, Inc. (“Terran”), a biotech platform company dedicated to the development of
Read More